S Fénard

732 total citations
20 papers, 624 citations indexed

About

S Fénard is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, S Fénard has authored 20 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 6 papers in Physiology. Recurrent topics in S Fénard's work include Heart Rate Variability and Autonomic Control (6 papers), Veterinary Pharmacology and Anesthesia (4 papers) and Pain Mechanisms and Treatments (3 papers). S Fénard is often cited by papers focused on Heart Rate Variability and Autonomic Control (6 papers), Veterinary Pharmacology and Anesthesia (4 papers) and Pain Mechanisms and Treatments (3 papers). S Fénard collaborates with scholars based in France and United States. S Fénard's co-authors include Mme Hélène Schmitt, Henri Schmitt, H Schmitt, Icilio Cavero, Alan G. Roach, H. Schmitt, Roberto Goméni, J. M. Maixent, A Autret and Richard M. Kawamoto and has published in prestigious journals such as Journal of Neurochemistry, European Heart Journal and Cellular and Molecular Life Sciences.

In The Last Decade

S Fénard

20 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Fénard France 11 313 248 173 118 61 20 624
H Schmitt France 11 235 0.8× 237 1.0× 200 1.2× 113 1.0× 38 0.6× 21 567
Langer Sz 8 480 1.5× 481 1.9× 180 1.0× 114 1.0× 43 0.7× 16 797
J.R. Boissier France 10 297 0.9× 326 1.3× 117 0.7× 171 1.4× 28 0.5× 16 788
L. Hedler Germany 20 428 1.4× 390 1.6× 215 1.2× 207 1.8× 41 0.7× 38 865
Mjmc Thoolen Netherlands 15 418 1.3× 295 1.2× 222 1.3× 144 1.2× 50 0.8× 32 653
S Huković Bosnia and Herzegovina 9 322 1.0× 246 1.0× 192 1.1× 170 1.4× 39 0.6× 35 715
M.W. McCulloch Australia 16 500 1.6× 407 1.6× 228 1.3× 162 1.4× 63 1.0× 47 877
Mme Hélène Schmitt France 10 385 1.2× 371 1.5× 234 1.4× 215 1.8× 58 1.0× 10 951
Matts Henning Sweden 15 178 0.6× 203 0.8× 154 0.9× 82 0.7× 46 0.8× 34 508
Ronald D. Robson Switzerland 15 221 0.7× 178 0.7× 102 0.6× 143 1.2× 28 0.5× 33 575

Countries citing papers authored by S Fénard

Since Specialization
Citations

This map shows the geographic impact of S Fénard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Fénard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Fénard more than expected).

Fields of papers citing papers by S Fénard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Fénard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Fénard. The network helps show where S Fénard may publish in the future.

Co-authorship network of co-authors of S Fénard

This figure shows the co-authorship network connecting the top 25 collaborators of S Fénard. A scholar is included among the top collaborators of S Fénard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Fénard. S Fénard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maixent, J. M., et al.. (1992). Efficacy and safety of the novel Na+,K(+)-ATPase inhibitor 20R 14 beta-amino 3 beta-rhamnosyl 5 beta-pregnan 20 beta-ol in a dog model of heart failure.. PubMed. 42(11). 1301–5. 6 indexed citations
2.
Maixent, J. M., S Fénard, & Richard M. Kawamoto. (1991). Tissue Localization of Active Na, K-ATPase Isoenzymes by Determination of their Profile of Inhibition with Ouabain, Digoxin, Digitoxigenin and LND 796, A new Aminosteroid Cardiotonic. Journal of Receptor Research. 11(1-4). 687–698. 22 indexed citations
3.
Fénard, S, et al.. (1988). Alpha subunits (alpha and alpha+) isoforms of the Na+, K+-ATPase in dog heart. Alteration of alpha+ in ischemia.. PubMed. 268B. 263–8. 2 indexed citations
4.
Koenig, Julie, et al.. (1984). A new inotropic aminosteroid: LND 623. European Heart Journal. 5(suppl F). 309–314. 9 indexed citations
5.
Cavero, Icilio, et al.. (1979). Preliminary studies on SL 75212, a new potent cardioselective beta-adrenoceptor antagonist [proceedings].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 66(3). 445P–445P. 37 indexed citations
6.
Cavero, Icilio, et al.. (1978). Studies on the mechanism of the vasodilator effects of prazosin in dogs and rabbits. European Journal of Pharmacology. 49(3). 259–270. 52 indexed citations
7.
Fénard, S, et al.. (1977). Vascular β-adrenoceptor stimulating properties of phenylphrine. European Journal of Pharmacology. 43(1). 85–88. 19 indexed citations
8.
Cavero, Icilio, et al.. (1977). Studies on the rebound hypertension after clonidine withdrawal in conscious hypertensive cats, rats, and dogs [proceedings].. PubMed. 60(2). 288P–289P. 3 indexed citations
9.
Schmitt, H & S Fénard. (1974). A technique for recording sympathetic nerve activity in unanaesthetized dogs. Neuropharmacology. 13(5). 347–351. 17 indexed citations
10.
Schmitt, H & S Fénard. (1973). Decrease in the sympatho-inhibitory action of clonidine after destruction of the sympatho-inhibitory area. Cellular and Molecular Life Sciences. 29(10). 1247–1249. 15 indexed citations
11.
Schmitt, H & S Fénard. (1973). Action of -adrenergic blocking drugs on the sympathetic centres and their interactions with the central sympatho-inhibitory effect of clonidine.. PubMed. 23(1). 40–5. 118 indexed citations
12.
Schmitt, Henri, Mme Hélène Schmitt, & S Fénard. (1973). Localization of the site of the central sympatho-inhibitory action of l-Dopa in dogs and cats. European Journal of Pharmacology. 22(2). 212–216. 9 indexed citations
13.
Schmitt, Henri, Mme Hélène Schmitt, & S Fénard. (1972). New evidence for an α-adrenergic component in the sympathetic centres: Centrally mediated decrease in sympathetic tone by 1-dopa and its antagonism by piperoxane and yohimbine. European Journal of Pharmacology. 17(2). 293–296. 30 indexed citations
14.
Schmitt, Henri, Mme Hélène Schmitt, & S Fénard. (1971). Evidence for an α-sympathomimetic component in the effects of catapresan on vasomotor centres: Antagonism by piperoxane. European Journal of Pharmacology. 14(1). 98–100. 230 indexed citations
15.
Schmitt, H. & S Fénard. (1971). [Effect of sympathomimetics on the vasomotor centers].. PubMed. 190(2). 229–40. 10 indexed citations
16.
Autret, A, et al.. (1971). Comparison of haemodynamic effects of α-sympathomimetic drugs. European Journal of Pharmacology. 13(2). 208–217. 31 indexed citations
17.
Schmitt, H & S Fénard. (1971). [Alterations of the electrical response of sympathetic nerves to acute hypotension by diazoxide].. PubMed. 24(3). 523–30. 1 indexed citations
18.
Duhault, J & S Fénard. (1965). [Study on the excretion, localization and metabolism of a new anorexigenic substance: fenfluramine].. PubMed. 158(2). 251–64. 3 indexed citations
19.
Gonnard, P, J Duhault, & S Fénard. (1964). ACTION DE L'α‐METHYL‐HYDRAZINO‐DOPA ET DE SON HYDRAZONE DE PHOSPHO‐5′‐PYRIDOXAL SUR LES DECARBOXYLASES D'AMINO‐ACIDES. Journal of Neurochemistry. 11(11). 819–824. 2 indexed citations
20.
Gonnard, P & S Fénard. (1962). DÉCARBOXYLASE GLUTAMIQUE ET HYDRAZONES DE PHOSPHO‐5‐PYRIDOXAL. Journal of Neurochemistry. 9(2). 135–142. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H Schmitt Breakdown of academic impact, for papers by Langer Sz Breakdown of academic impact, for papers by J.R. Boissier Breakdown of academic impact, for papers by L. Hedler Breakdown of academic impact, for papers by Mjmc Thoolen Breakdown of academic impact, for papers by S Huković Breakdown of academic impact, for papers by M.W. McCulloch Breakdown of academic impact, for papers by Mme Hélène Schmitt Breakdown of academic impact, for papers by Matts Henning Breakdown of academic impact, for papers by Ronald D. Robson
Rankless by CCL
2026